Dashboard
Manage Tickers

ALLRAllarity Therapeutics, Inc.

Nasdaq allarity.com


$ 3.39 $ -0.02 (-0.59 %)    

Monday, 16-Sep-2024 09:34:00 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.60 $ -0.46 (-0.1 %)
DIA $ 417.45 $ 0.50 (0.12 %)
SPY $ 562.08 $ 0.61 (0.11 %)
TLT $ 100.59 $ -0.04 (-0.04 %)
GLD $ 238.30 $ -0.30 (-0.12 %)
$ 3.41
$ 3.39
$ 3.25 x 100
-- x --
$ 3.39 - $ 3.39
$ 2.58 - $ 666.00
1,395,587
na
4.82M
$ 1.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-08-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-13-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 10-07-2022 06-30-2022 10-Q
10 05-27-2022 03-31-2022 10-Q
11 05-16-2022 09-30-2021 10-Q
12 05-16-2022 12-31-2021 10-K
13 11-23-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

allarity-therapeutics-announces-2-patients-now-exceeding-1-year-of-treatment-with-stenoparib-in-advanced-ovarian-cancer-trial
Allarity Therapeutics Announces 2 Patients...
09/16/2024 12:20:52

- Durable Clinical Benefit Observed Beyond a Year on Treatment in Heavily Pre-Treated Patients Boston (September 16, 2024) — Al...

allarity-therapeutics-appoints-alex-epshinsky-as-cfo
Allarity Therapeutics Appoints Alex Epshin...
09/13/2024 12:51:08

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
09/11/2024 12:55:05

allarity-therapeutics-implements-1-for-30-reverse-stock-split-to-regain-nasdaq-listing-compliance
Allarity Therapeutics Implements 1-for-30 ...
09/11/2024 12:08:25

Shareholders Approved The Split At September 3, 2024 Annual Meeting, And Split Took Effect On September 11, 2024

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
09/10/2024 23:50:04

allarity-therapeutics-increases-common-stock-offering-size-from-30m-to-50m
Allarity Therapeutics Increases Common Sto...
09/09/2024 20:13:27

allarity-therapeutics-files-for-offering-of-up-to-185m-shares-by-the-selling-stockholders
Allarity Therapeutics Files For Offering O...
08/30/2024 20:08:03

- SEC Filing

allarity-therapeutics-13g-filing-shows-streeterville-capital-llc-reported-a-147-stake-in-the-co-as-of-august-19-2024
Allarity Therapeutics 13G Filing Shows Str...
08/29/2024 20:01:34

- SEC Filing

allarity-therapeutics-postpones-annual-meeting-of-stockholders-originally-scheduled-for-july-26-2024
Allarity Therapeutics Postpones Annual Mee...
07/26/2024 13:03:27

why-general-dynamics-shares-are-trading-lower-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why General Dynamics Shares Are Trading Lo...
07/24/2024 17:26:11

why-enphase-energy-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why Enphase Energy Shares Are Trading High...
07/24/2024 09:27:11

allarity-therapeutics-hit-by-sec-notice-related-disclosures-of-once-lead-cancer-program
Allarity Therapeutics Hit By SEC Notice Re...
07/22/2024 16:30:04

Allarity Therapeutics receives a Wells Notice from the SEC regarding disclosures about their FDA meetings for the New Drug Appl...

allarity-received-a-wells-notice-from-sec-relating-to-its-disclosures-regarding-meetings-with-the-fda-regarding-nda-for-dovitinib-or-dovitinib-drp-which-was-submitted-in-2021-allaritys-three-former-officers-have-received-the-notice
Allarity Received A "Wells Notice" From SE...
07/22/2024 12:02:19

Current Cash Balance of $20 million Expected to Provide Runway Into 2026 Allarity to Pause Use of ATM Cap Table Successfull...

sec-issues-wells-notice-to-allarity-therapeutics-and-former-officers-over-2021-fda-nda-submission
SEC Issues Wells Notice to Allarity Therap...
07/22/2024 10:22:32

On July 19, 2024, Allarity Therapeutics, Inc. (the “Company”) received a “Wells Notice” from the Staff of the U.S. Securities a...

why-aslan-pharmaceuticals-shares-are-trading-lower-by-over-38-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why ASLAN Pharmaceuticals Shares Are Tradi...
07/17/2024 17:28:51

allarity-therapeutics-shares-are-trading-higher-after-the-company-announced-that-it-received-notice-from-the-nasdaq-stock-market-that-it-was-granted-a-hearing
Allarity Therapeutics shares are trading h...
06/27/2024 12:16:30

allarity-granted-hearing-before-nasdaq-panel-to-present-plan-of-regaining-compliance
Allarity Granted Hearing Before Nasdaq Pan...
06/27/2024 12:02:30

Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR), a Phase 2 clinical-stage pharmaceutica...

allarity-therapeutics-dual-parptankyrase-inhibitor-stenoparib-to-show-extended-clinical-benefit-in-advanced-ovarian-cancer
Allarity Therapeutics' Dual PARP/Tankyrase...
06/25/2024 12:09:37

Multiple patients have now exceeded 30 weeks on treatment Boston (June 25, 2024)—Allarity Therapeutics, Inc. ("Allarity"...

why-allarity-therapeutics-allr-stock-is-getting-hammered
Why Allarity Therapeutics (ALLR) Stock Is ...
06/24/2024 20:28:26

Allarity Therapeutics shares are trading lower by 27.6% during Monday's session. The company announced that it received a n...

dow-jumps-300-points-alimera-sciences-shares-spike-higher
Dow Jumps 300 Points; Alimera Sciences Sha...
06/24/2024 17:06:48

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION